Thyroid-stimulating hormone (TSH) and insulin-like growth factor-i (IGF-1) synergistically stimulate DNA synthesis in thyroid cells. In this report, a novel mechanism for mediation of this synergistic interaction is described in rat thyroid (FRTL-5) cells. Because phorbol myristate acetate stimulates DNA synthesis, the effects of TSH, IGF-1 and insulin on FRTL-5 cell content of 1,2-diacylglycerol (1,2-DG), the endogenous activator of protein kinase C, were measured. After 6 d, TSH, IGF-1 and insulin caused increases in cellular 1,2-DC (mean±SE) to 180±10%, 540±50%, and 360±40% of control, respectively, whereas TSH plus IGF-1 and TSH plus insulin synergistically increased 1,2-DG to 1,890±310% and 1,690±230%, respectively. In the absence of insulin, the effect of TSH to elevate 1,2-DG exhibited an EC50 of -2,000 sU/ml. The synergistic interaction of insulin and TSH was found to increase the potency of TSH by 300-fold (ECQO was 7 ;&U/ml) in addition to increasing the efficacy of TSH. The effect of TSH appeared to be mediated by TSH-stimulated increases in cyclic AMP (cAMP). Forskolin and 8-bromocAMP, like TSH, caused modest increases in 1,2-DG and DNA synthesis, whereas forskolin plus insulin and 8-bromocAMP plus insulin markedly elevated 1,2-DG content and stimulated DNA synthesis. Under all conditions, increases in 1,2-DC content correlated with stimulation of DNA synthesis.
Introduction
The intracellular pathways that mediate the actions of growth factors have been intensively investigated during the last sev-eral years (reviewed in references 1-3). Although our understanding of the mediators of growth factor action is still very limited, evidence has accumulated suggesting that 1,2-diacylglycerol (1 ,2-DG),' via activation of protein kinase C (see reference 4 for review), and cyclic 3':5'-adenosine monophosphate (cAMP) play important roles in the action of several growth factors. Thyrotropin (thyroid-stimulating hormone, TSH) and insulin-like growth factor-I (IGF-1) or high doses of insulin, which allows for interaction with receptors for IGF-1, are factors that stimulate growth of thyroid cells (5) (6) (7) (8) (9) (10) (11) (12) . TSH appears to act by stimulating adenylyl cyclase and elevating cAMP (9-11, but 12) , whereas the mechanism of action of IGF-1 or high doses of insulin is not known but may involve activation of the IGF-1 receptor tyrosine kinase ( 13) . Most interestingly, and perhaps most relevant under normal physiologic conditions, TSH and IGF-l have been found to synergistically stimulate DNA synthesis in thyroid cells (5, 6, 8, 9) . Because activation ofprotein kinase C has been implicated as a mediator of mitogenesis in thyroid cells (8, 14, 15) , the effects of TSH, IGF-1 and insulin on thyroid cell content of 1 ,2-DG were measured. These growth factors caused a persistent elevation of I,2-DG in a cloned line of rat thyroid (FRTL-5) cells. Moreover, there was a profound synergistic effect of TSH plus IGF-l (or high doses of insulin) on cell 1,2-DG content that could be mimicked by the cAMP analogue, 8- 1,2-DG content is calculated from the 32P-radioactivity in phosphatidic acid and the specific activity of the gamma-[32P]ATP. Measurement of inorganic phosphorus content was also performed on aliquots of the lower phase cell extract ( 19) . Statistical analysis. Analyses were made by t test; P values < 0.05 were considered significant.
Results and Discussion
To investigate the mechanism(s) of stimulation of DNA synthesis in FRTL-5 thyroid cells by TSH, IGF-l and insulin, we have established serum-, hormone-, and growth factor-free culture conditions ("basal medium") that supports FRTL-5 cell viability and responsiveness to mitogenic factors. FRTL-5 cells incubated in basal medium for 7 d ("basal cells") can resume growth at a rate indistinguishable from control cells when reexposed to complete 6H medium and can be maintained in basal medium for up to 3 wk (data not shown). Because (a) phorbol ester-induced activation of protein kinase C has been reported to be mitogenic in thyroid cells (8, [ there was a marked increase in the potency as well as the efficacy of TSH. The marked elevation of 1,2-DG content and stimulation of DNA synthesis were attained with TSH concentrations that were within the physiologic range, EC50 of -7 uU/ml. There was an additional small increase in 1,2-DG content at high doses of TSH in the presence of insulin that corresponds to the elevation of 1,2-DG caused by high concentrations of TSH alone. The observed increase in potency of TSH in the presence of high doses of insulin was most likely not caused by changes in receptors for TSH because IGF-1 alone has no effect on TSH binding to FRTL-5 cells and IGF-1 enhances the effect of TSH to decrease TSH binding (22) . Hence, the synergism of the interaction of TSH and IGF-1 (or high doses of insulin) not only allows for increased efficacy of TSH at maximum concentrations but, more importantly, permits a marked increase in the potency of TSH such that the responses occur at concentrations that are within the physiologic range.
Finally, since TSH acutely stimulates adenylyl cyclase in FRTL-5 cells and cAMP appears to mediate, at least in part, the effects of TSH to stimulate DNA synthesis (9-1 1 possible that cAMP was a proximal mediator of the TSH-induced increase in 1,2-DG. Fig. 4 compares the effiects of TSH, forskolin, a direct stimulator of adenylyl cyclase, and BrcAMP, a cAMP analogue, alone or in combination with insulin, on cellular 1,2-DG content and DNA synthesis. TSH, forskolin, or BrcAMP alone all caused similar small increases in 1,2-DG content. When each factor was combined with insulin a synergistic increase was observed to levels that were not different from one another. In this series of experiments, insulin plus TSH, insulin plus forskolin, or insulin plus BrcAMP caused an approximately eightfold increase in 1,2-DG content. TSH, forskolin or BrcAMP alone all significantly stimulated DNA synthesis, however, TSH was approximately twice as effective as either forskolin or BrcAMP. In this series of experiments, insulin alone caused a 9.5-fold increase in DNA synthesis; this is smaller than that found in the experiments shown in Fig. 2 (Fig. 3) . Because the measurements made were oftotal cellular 1,2-DG, it was possible that the observed elevations included pools of 1,2-DG that did not serve a regulatory role to activate protein kinase C. For example, the increases may have occurred in pools that are intermediates in de novo lipid synthesis. However, three findings are consistent with the hypothesis that the elevated 1,2-DG content is functionally related to the enhanced DNA synthesis. First, the increases in cellular 1,2-DG content correlated with increases in DNA synthesis in a highly significant manner (r = 0.73, P < 0.001). Second, the synergistic stimulation of DNA synthesis observed at 18 h was preceded by an increase in 1,2-DG content at 9 h. Third, pretreatment of these cells with phorbol esters, which we have found to down-regulate protein kinase C activity (unpublished observation) causes marked inhibition ofthe synergistic stimulation of DNA synthesis by TSH plus IGF-1.
The mechanism by which TSH, via cAMP, and IGF-1 interact to synergistically increase 1,2-DG content of thyroid cells is not known. It has been suggested that an extracellular signal acting via cAMP could rapidly stimulate de novo lipid synthesis (23) . Also, other investigators (24, 25) have reported that TSH acutely stimulates phospholipase C-mediated hydrolysis of inositol lipids in FRTL-5 cells and it was possible that 1,2-DG could have been formed by this mechanism. Recent experiments in our laboratory, however, indicate that the synergistic elevation of 1,2-DG is not a rapid process because no increase in 1,2-DG was found at early time points and up until 6 h of exposure to TSH plus insulin (data not shown). Moreover, the stimulation by TSH of inositol lipid hydrolysis reported by others (24, 25) occurred only with concentrations of TSH that were many fold higher than needed to synergistically stimulate DNA synthesis and elevate 1,2-DG content in FRTL-5 cells. We have not observed any acute effect of TSH on inositol lipid hydrolysis with concentrations up to 30,000 uU/ml. Hence, rapid stimulation of de novo lipid synthesis or of hydrolysis of inositol lipids does not explain the increase in 1,2-DG mass reported here. It is possible that a delayed phospholipase C-mediated hydrolysis of inositol lipids or of another lipid, for example, phosphatidylcholine may be involved. It seems more likely, however, that these persistent effects of TSH and IGF-1 are mediated at the transcriptional level to induce enzymes of lipid synthesis, such as glycerol 3-phosphate acyltransferase or phosphatidic acid phosphohydrolase, and thereby stimulate formation of 1,2-DG.
Our studies suggest that protein kinase C activation resulting from the synergistic interaction of TSH, via cAMP, and IGF-1 to elevate cellular 1 ,2-DG levels, is an important modulator of DNA synthesis in thyroid cells. Our finding that two growth factors can interact to elevate cellular 1,2-DG levels suggests a novel site of interaction between the lipid and adenylyl cyclase signaling systems for the regulation of cell growth.
